Skip to main content
. 2022 Sep 22:10.1111/cbdd.14136. Online ahead of print. doi: 10.1111/cbdd.14136

FIGURE 1.

FIGURE 1

Illustration of the CADD pipeline based on the availability or unavailability of 3D information of the target. The ultimate aim of this process is to obtain a lead compound to be identified as a drug candidate when the desired results from in vitro/in vivo testing are expected (redesigned by the authors of present work with permission from; Imam & Gilani, 2017